Full Text View
Tabular View
No Study Results Posted
Related Studies
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
This study has been completed.
Study NCT00221442   Information provided by Lindner Center of HOPE
First Received: September 14, 2005   Last Updated: March 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Bulimia
Bulimia Nervosa
Disease
Eating Disorders
Obesity
More general conditions related to this trial
Body Weight
Hyperphagia
Mental Disorders
Nutrition Disorders
Overnutrition
Overweight
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Zonegran
Additional drug interventions recognized in this trial
Zonisamide
More general drug interventions related to this trial
Anticonvulsants
Antioxidants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Lindner Center of HOPE
Eisai Inc.
University of Cincinnati


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services